Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy Life Science Investing
NeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior Notes Life Science Investing
Innovotech Inc. Announces CFO Transition and Reports 2026 Annual General Meeting Result Life Science Investing
Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026 Life Science Investing
Enveric Biosciences Announces Participation in 2026 BIO International Convention Life Science Investing
TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&D to Commercial Scale Life Science Investing
Pasithea Therapeutics Announces Amendments to Clinical Study Protocol for Phase 1/1B NF1 Clinical Trial Life Science Investing
HCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata Life Science Investing
NeoGenomics Announces Proposed Offering of $275 Million Convertible Senior Notes Life Science Investing
As the Ebola Epidemic Spreads, NV-387 Oral Gummies Can Enter a Phase II Clinical Trial for Treatment of Ebola - NanoViricides Proposal is Approved by the Pillar Committee in DR Congo Life Science Investing
The Radoff-JEC Group Highlights Seer Inc.'s and Chairman and CEO Omid Farokhzad, M.D.'s History of Value Destruction Life Science Investing
